Brand: Thyrostim / Thyroxine (as supplied)
Composition: Levothyroxine Sodium BP / IP, equivalent to anhydrous Levothyroxine Sodium
Documented strengths: 25 mcg, 50 mcg, 100 mcg (0.1 mg) and 250 mcg (0.25 mg)
Usage: Treatment of hypothyroidism; other approved thyroid-related indications depend on prescribing information.
Category: Thyroid Hormones
Therapeutic category: Thyroid hormone replacement (synthetic T4)
SKU: Thyroxin Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Thyroxin Tablets Exporter is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
For international B2B procurement, confirm the destination-country registration, import permits, product labelling, shelf life and availability of export documentation before placing orders. Regulatory approvals and export eligibility vary by market.
Levothyroxine sodium is a synthetic form of thyroxine (T4), a thyroid hormone used to replace deficient hormone in people with hypothyroidism. Healthy Life Pharma Pvt. Ltd. is identified in the supplied product information as the manufacturer and Healthy Inc as the exporter. Claims about facility certifications, manufacturing capabilities and export authorizations require documentary verification.
Levothyroxine has a narrow therapeutic index: consistent dose, administration and follow-up testing are essential. It is not indicated for weight loss in people with normal thyroid function.
| Product / Standard | Strength | Active ingredient |
|---|---|---|
| Thyrostim Tablets BP | 100 mcg (0.1 mg) | Levothyroxine sodium BP, equivalent to anhydrous levothyroxine sodium |
| Thyroxine Sodium Tablets BP | 250 mcg (0.25 mg) | Levothyroxine sodium BP, equivalent to anhydrous levothyroxine sodium |
| Levothyroxine Sodium Tablets IP | 50 mcg | Levothyroxine sodium IP, equivalent to anhydrous levothyroxine sodium |
| Thyroxine / Thyroxin Tablets IP | 25 mcg | Levothyroxine sodium IP, equivalent to anhydrous levothyroxine sodium |
Dosage form: Uncoated tablet. CAS: 55-03-8 (levothyroxine sodium). Therapeutic class: Thyroid hormone. Packaging, shelf life and release specifications: Verify against approved product records. Additional strengths (75, 88, 112, 125, 150 and 200 mcg) mentioned in the supplied marketing description are not confirmed by the supplied compositions.
Microgram-dose tablets require validated blending, content-uniformity controls and careful management of moisture, heat and light exposure. Exact excipients, processing methods, color coding and protective packaging should be described only as supported by the manufacturer's approved batch records and stability data.
Relevant quality controls include identity, assay, content uniformity, dissolution, related substances and stability testing under the applicable approved pharmacopoeial specification. Specific numerical acceptance criteria or bioequivalence claims must be verified against the actual product's approved documentation.
Levothyroxine supplies T4, which is converted in tissues to the active hormone T3. It supports normal metabolism and organ function. It is used primarily for hypothyroidism and may be prescribed for selected thyroid-cancer-related TSH suppression indications under specialist supervision. It must not be used as a weight-loss medicine.
Export-focused B2B review includes destination-country requirements, commercial invoice, packing list, certificates of analysis and other documents when available and applicable.
For B2B enquiries, confirm the availability and validity of country-specific registrations, CTD/ACTD dossiers, certificates of analysis, manufacturing licences, COPP/FSC and shipping arrangements directly with the supplier. WHO-GMP certification and regulatory-market approval are not independently verified by this page.
What strengths are listed? The supplied product compositions document 25 mcg, 50 mcg, 100 mcg and 250 mcg. Note that 0.1 mg = 100 mcg and 0.25 mg = 250 mcg.
Can brands or formulations be switched? Consult the prescriber; TSH monitoring may be needed after a change in product.
Can levothyroxine be taken with calcium or iron? These supplements can reduce absorption; they are generally separated from levothyroxine by at least four hours, as directed by the prescribing information.
Can it be used for weight loss? No. Thyroid hormones should not be used to treat obesity in euthyroid patients.
Dosage is individualized by the treating clinician using clinical status, age, cardiac risk and thyroid laboratory results. Oral levothyroxine is generally taken once daily on an empty stomach, 30–60 minutes before breakfast, consistently with water. The 250 mcg strength is a relatively high strength and must not be mistaken for 25 mcg. Do not change the dose or discontinue treatment without medical advice.
Excess thyroid replacement can cause palpitations, tremor, anxiety, insomnia, heat intolerance, arrhythmias and bone loss. Patients with coronary disease and older adults may need cautious dose adjustment. Calcium, iron and certain antacids can interfere with absorption. Monitoring of TSH (and free T4 when appropriate) guides treatment. Untreated adrenal insufficiency is an important contraindication until corrected.
Store according to the approved pack label, protected from excessive heat, moisture and light. Do not assume a universal shelf life or storage-temperature limit without product-specific stability data. Keep out of reach of children.